CROSS-BORDER AI-DRIVEN

LIFESCIENCE VENTURE STUDIO

Transforming bold ideas into intelligent ventures

About Us

bioHUB NewCo Inc a Cross-border Data-Driven Lifescience Venture Studio company registered in North America and Asia, created and invested by bioHUB Labs Inc with a focus on licensing and commercialization of “Pre-Clinical and Clinical Stage“ Oncology Immuno-Oncology, Metabolic and Rare Diseases Intellectual Property (IP) through a NewCo (a newly formed, independent startup entity).

The Challenge

  • Legislation: The BIOSECURE Act enacted in December 2025 as part of the FY2026 National Defense Authorization Act, restricts U.S. federal agencies and contractors from using biotechnology equipment or services from designated “foreign adversary” firms.
  • US biotech Market: US biotech sector is experiencing a bifurcation, with larger companies facing sharp downgrades due to valuation concerns, and smaller firms struggle with capital constraints resulting in bankruptcy.
  • Innovation: While the US leads in foundational AI innovation, China dominates in real-world application, “AI-first” drug discovery pipelines, and speed.

Services

Business Model

NewCo Business Model

The biopharma sector is undergoing a transformative evolution, driven by the emergence of NewCo’s—innovative, newly established entities designed to advance specific drug assets on a global scale.

Why Use the NewCo Model

The NewCo model has gained massive traction for several core reasons:

Structural Breakdown

Asset Licensing: The originating company grants the NewCo an exclusive, localized, or global license to develop and commercialize the specific compound or technology.

Portfolio

CHECK OUR PORTFOLIO

  • All
  • Oncology
  • Metabolic
  • Immune
  • CNS

Team

CHECK OUR TEAM

Sherida Johnson PhD

Sherida Johnson PhD

Co-Founder Director & CEO
Yuan Tian PhD

Yuan Tian PhD

Co-Founder Managing Director/Partner
Suresh Gorle PhD

Suresh Gorle PhD

Co-Founder Managing Director/Partner
Daren Singh

Daren Singh

Co-Founder Managing Director/Partner
J. Srimathi Devi PhD

J. Srimathi Devi, PhD

Co-Founder Managing Director / Partner
Nabila Berrabia

Nabila Berrabia

Co-Founder Managing Director / Partner
Lab Research

LABSYNX, a data-driven Venture Studios headquartered in Auburn, Hong Kong and Malaysia, aims to focus on the development of AI-Driven Microfluidics platform companies that supports AI-Driven Pre-Clinical Drug Testing platforms and services.

Partners

Contact

Get In Touch with Us!

Address

2010 El Camino Real #1076 Santa Clara, CA 95050

Call Us

408-250-2178

Email Us

contact@biohublabs.com

Loading
Your message has been sent. Thank you!